Photo source: Facebook
Drug companies in India and China are drooling over the prospect that many American jobs in the pharmaceutical industry could soon be outsourced overseas.
The reason? A recent announcement from the U.S. Food and Drug Administration (FDA) that it is exploring so-called “importation” proposals, which would open the foreign drug market to Americans at rates set arbitrarily by other governments.
“The doors appear to be opening,” reports an industry newspaper the Pharma Letter, calling the development a “major positive for the India pharma industry.”
Read more: DRUG PROPOSAL COULD BE MAJOR JOB CREATOR IN INDIA, CHINA
